PortalPublikationenMarine Compounds and Cancer: The First Two Decades of XXI Ce...

Marine Compounds and Cancer: The First Two Decades of XXI Century

Standard

Marine Compounds and Cancer: The First Two Decades of XXI Century. / Dyshlovoy, Sergey A; Honecker, Friedemann.

in: MAR DRUGS, Jahrgang 18, Nr. 1, 26.12.2019.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Dyshlovoy, SA & Honecker, F 2019, 'Marine Compounds and Cancer: The First Two Decades of XXI Century', MAR DRUGS, Jg. 18, Nr. 1. https://doi.org/10.3390/md18010020

APA

Dyshlovoy, S. A., & Honecker, F. (2019). Marine Compounds and Cancer: The First Two Decades of XXI Century. MAR DRUGS, 18(1). https://doi.org/10.3390/md18010020

Vancouver

Dyshlovoy SA, Honecker F. Marine Compounds and Cancer: The First Two Decades of XXI Century. MAR DRUGS. 2019 Dez 26;18(1). https://doi.org/10.3390/md18010020

Bibtex

@article{5b0ea327c4b147fd810975ccb105f066,
title = "Marine Compounds and Cancer: The First Two Decades of XXI Century",
abstract = "In 2019, the scientific and medical community celebrated the 50th anniversary of the introduction of the very first marine-derived drug, Cytarabine, into clinics [...].",
author = "Dyshlovoy, {Sergey A} and Friedemann Honecker",
note = "Editorial",
year = "2019",
month = dec,
day = "26",
doi = "10.3390/md18010020",
language = "English",
volume = "18",
journal = "MAR DRUGS",
issn = "1660-3397",
publisher = "MDPI AG",
number = "1",

}

RIS

TY - JOUR

T1 - Marine Compounds and Cancer: The First Two Decades of XXI Century

AU - Dyshlovoy, Sergey A

AU - Honecker, Friedemann

N1 - Editorial

PY - 2019/12/26

Y1 - 2019/12/26

N2 - In 2019, the scientific and medical community celebrated the 50th anniversary of the introduction of the very first marine-derived drug, Cytarabine, into clinics [...].

AB - In 2019, the scientific and medical community celebrated the 50th anniversary of the introduction of the very first marine-derived drug, Cytarabine, into clinics [...].

U2 - 10.3390/md18010020

DO - 10.3390/md18010020

M3 - Other (editorial matter etc.)

C2 - 31887976

VL - 18

JO - MAR DRUGS

JF - MAR DRUGS

SN - 1660-3397

IS - 1

ER -